On Tuesday, Pfizer pharmaceutical giant CEO Albert Bourla said, Pfizer is ‘very close’ to submitting for an emergency use authorisation for its Covid-19 vaccine to the US regulators after collecting the safety data. Last week it announced the preliminary results of it’s vaccine which it co-developed with Germany’s BioNTech which said it to be 90% effective after the second dose. They will be applying for the emergency use authorisation by third week of November.
Pfizer to apply for US emergency approval, says Pfizer CEO
